Hutchinson Center as Lead Academic Participating Site (UG1)

哈钦森中心作为主要学术参与站点 (UG1)

• 批准号: 10642656
• 负责人: Evan Yu
• 金额: $ 49.56万
• 依托单位: FRED HUTCHINSON CANCER CENTER
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-03-06 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10642656
• 关键词: Achievement; Adult; Alaska; American College of Radiology Imaging Network; Cancer Center; Clinical; Clinical Research; Clinical Treatment; Clinical Trials; Clinical Trials Network; Conduct Clinical Trials; Country; Development; Diagnosis; Disease; Fred Hutchinson Cancer Research Center; Goals; Idaho; Imaging Techniques; Individual; Infrastructure; Institution; Investigation; Lead; Leadership; Malignant Neoplasms; Montana; NCI Center for Cancer Research; National Cancer Institute; National Clinical Trials Network; Patients; Persons; Phase; Randomized; Research; Role; Shapes; Site; Southwest Oncology Group; Special Population; United States; Washington; Work; Wyoming; base; cancer prevention; cancer therapy; clinical imaging; innovation; insight; member; next generation; novel strategies; phase III trial; pre-clinical research; programs; rare cancer; research study; treatment trial

Project Summary/ Abstract The goal of the NCI National Clinical Trials Network (NCTN) is to develop and conduct state-of-the-art cancer treatment and advanced imaging clinical trials, especially large, definitive multi-institutional trials evaluating new cancer therapies and related clinical approaches. NCTN Lead Academic Participating Sites (LAPS) are one component of this network and will provide scientific leadership in the development and conduct of NCTN clinical trials in association with one or more adult Network Groups as well as substantial accrual to clinical trials conducted across the entire NTCN. The Fred Hutchinson Cancer Research Center (Fred Hutch) is among the nation’s leading cancer centers and is the only NCI-designated comprehensive cancer research center serving the WWAMI (Washington, Wyoming, Alaska, Montana and Idaho) region. The broad and deep pre-clinical and clinical research programs at Fred Hutch will support the NCTN Program in three major ways: (1) The scientific expertise of the members of Fred Hutch will continue to contribute to the leadership of the NCTN program through their activities directly at the NCI and in SWOG, NRG and ACRIN. (2) The innovative pre-clinical and clinical research studies at Fred Hutch will provide the preliminary information necessary to shape the next generation of cooperative group trials. (3) The large patient base at Fred Hutch combined with expert clinicians and clinical trials infrastructure will assure substantial accrual to NCTN trials. Fred Hutchinson Cancer Research Center and its partners are committed to the goals of the National Clinical Trials Network (NCTN) and will work to provide leadership for our nation’s clinical trials network.

项目摘要/摘要 NCI国家临床试验网络（NCTN）的目标是开发和进行最先进的癌症 治疗和高级成像临床试验，尤其是大型，确定的多机构试验评估 新的癌症疗法和相关的临床方法。 NCTN领导学术参与地点（圈）是 该网络的一个组成部分，将在NCTN的发展和行为方面提供科学领导 与一个或多个成人网络组相关的临床试验以及临床的实质性准确性 在整个NTCN进行了试验。弗雷德·哈钦森癌症研究中心（Fred Hutch）是 在美国领先的癌症中心中，是NCI指定的综合癌症研究 中心为WWAMI（华盛顿，怀俄明州，阿拉斯加，蒙大拿州和爱达荷州）地区提供服务。宽阔而深 Fred Hutch的临床前和临床研究计划将以三种主要方式支持NCTN计划： （1）弗雷德·哈奇（Fred Hutch）成员的科学专业知识将继续为 NCTN通过他们的活动直接在NCI和SWOG，NRG和ACRIN进行计划。 （2）创新 Fred Hutch的临床前和临床研究将提供必要的初步信息 塑造下一代合作小组试验。 （3）Fred Hutch的大型患者基础与 专业的临床医生和临床试验基础设施将确保NCTN试验的实质性准确性。弗雷德·哈钦森 癌症研究中心及其合作伙伴致力于国家临床试验网络的目标 （NCTN），并将努力为我们国家的临床试验网络提供领导力。